The Valley Desk

ArticleACR open rheumatologyPublished

Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
ACR open rheumatology
Published
PubMed ID
36762512
PubMed Central ID
PMC10010489
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal